Prevalence and factors associated with preterm small-for-gestational-age neonates: a multi-center survey in China

Yi-Jie Zhang1, Chao Chen2

  • 1Department of Neonatology, Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao, 266003, China. zhangyijie@qdu.edu.cn.

BMC Pediatrics
|January 6, 2026
PubMed

Insights

Preterm small-for-gestational-age (SGA) infants face significant risks, with varying factors influencing outcomes based on gestational age. Hypertension disorders in pregnancy and placental abruption are key predictors for early preterm SGA, necessitating tailored interventions.

Area of Science:

  • Neonatal Health
  • Perinatal Medicine
  • Global Health Challenges

Background:

  • Small-for-gestational-age (SGA) infants pose significant global health risks, contributing to neonatal mortality and long-term developmental issues.
  • The risks associated with SGA infants are amplified when they are also born preterm, yet research in this specific population remains limited.

Purpose of the Study:

  • To investigate the prevalence of preterm SGA infants in China.
  • To identify factors associated with preterm SGA neonates across different gestational age subgroups.

Main Methods:

  • A retrospective descriptive cross-sectional study was conducted across 23 Chinese provinces between 2011 and 2017.
  • Data on maternal characteristics and medical history were collected from medical records.
  • Multinomial multivariate logistic regression was employed to compare preterm SGA subgroups with appropriate-for-gestational-age (AGA) preterm infants.

Main Results:

  • The prevalence of preterm SGA infants was 7.9% among singleton live-birth preterm infants.
  • Hypertension disorders in pregnancy (HDP) and Category III fetal heart rate tracings were significantly associated with preterm SGA across subgroups.
  • HDP was a strong predictor for early preterm SGA (<32 weeks), while Category III fetal heart rate tracings and oligohydramnios were more predictive of moderate preterm SGA (32-33 weeks). Placental abruption was also strongly associated with early and moderate preterm SGA.

Conclusions:

  • Preterm SGA infants exhibit distinct risk profiles based on gestational age subgroups.
  • Hypertension disorders in pregnancy and placental abruption are critical factors for early preterm SGA.
  • Interventions for preterm SGA should be tailored to specific gestational age categories for improved prevention and management.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240